RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
ExpreS2ion Biotech Holding Stock

ExpreS2ion Biotech Holding ROA 2024

ExpreS2ion Biotech Holding ROA

-1.16

Ticker

EXPRS2.ST

ISIN

SE0008348262

WKN

A2APAB

In 2024, ExpreS2ion Biotech Holding's return on assets (ROA) was -1.16, a 34.52% increase from the -0.86 ROA in the previous year.

ExpreS2ion Biotech Holding Aktienanalyse

What does ExpreS2ion Biotech Holding do?

ExpreS2ion Biotech Holding ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding ExpreS2ion Biotech Holding's Return on Assets (ROA)

ExpreS2ion Biotech Holding's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing ExpreS2ion Biotech Holding's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider ExpreS2ion Biotech Holding's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in ExpreS2ion Biotech Holding’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about ExpreS2ion Biotech Holding stock

What is the Return on Assets (ROA) of ExpreS2ion Biotech Holding this year?

The Return on Assets (ROA) of ExpreS2ion Biotech Holding is -1.16 undefined this year.

What was the ROA of ExpreS2ion Biotech Holding compared to the previous year?

The ROA of ExpreS2ion Biotech Holding has increased by 34.52% compared to the previous year.

What consequences do high ROA have for investors of ExpreS2ion Biotech Holding?

A high ROA is advantageous for investors of ExpreS2ion Biotech Holding, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in ExpreS2ion Biotech Holding?

A low ROA can be unfavorable for investors of ExpreS2ion Biotech Holding as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of ExpreS2ion Biotech Holding affect the company?

An increase in ROA of ExpreS2ion Biotech Holding can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of ExpreS2ion Biotech Holding impact the company?

A reduction in the ROA of ExpreS2ion Biotech Holding can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of ExpreS2ion Biotech Holding?

Some factors that can influence the ROA of ExpreS2ion Biotech Holding include revenue, operating costs, asset structure, and industry average.

Why is the ROA of ExpreS2ion Biotech Holding important for investors?

The ROA of ExpreS2ion Biotech Holding is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can ExpreS2ion Biotech Holding take to improve ROA?

To improve ROA, ExpreS2ion Biotech Holding can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does ExpreS2ion Biotech Holding pay?

Over the past 12 months, ExpreS2ion Biotech Holding paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, ExpreS2ion Biotech Holding is expected to pay a dividend of 0 SEK.

What is the dividend yield of ExpreS2ion Biotech Holding?

The current dividend yield of ExpreS2ion Biotech Holding is .

When does ExpreS2ion Biotech Holding pay dividends?

ExpreS2ion Biotech Holding pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of ExpreS2ion Biotech Holding?

ExpreS2ion Biotech Holding paid dividends every year for the past 0 years.

What is the dividend of ExpreS2ion Biotech Holding?

For the upcoming 12 months, dividends amounting to 0 SEK are expected. This corresponds to a dividend yield of 0 %.

In which sector is ExpreS2ion Biotech Holding located?

ExpreS2ion Biotech Holding is assigned to the 'Health' sector.

Wann musste ich die Aktien von ExpreS2ion Biotech Holding kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of ExpreS2ion Biotech Holding from 10/10/2024 amounting to 0 SEK, you needed to have the stock in your portfolio before the ex-date on 10/10/2024.

When did ExpreS2ion Biotech Holding pay the last dividend?

The last dividend was paid out on 10/10/2024.

What was the dividend of ExpreS2ion Biotech Holding in the year 2023?

In the year 2023, ExpreS2ion Biotech Holding distributed 0 SEK as dividends.

In which currency does ExpreS2ion Biotech Holding pay out the dividend?

The dividends of ExpreS2ion Biotech Holding are distributed in SEK.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von ExpreS2ion Biotech Holding

Our stock analysis for ExpreS2ion Biotech Holding Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of ExpreS2ion Biotech Holding Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.